Abstract
Background
The management of antithrombotic therapy in the patients undergoing gastric endoscopic submucosal dissection (ESD) is of concern. This study aimed to assess delayed bleeding rate after gastric ESD in the patients receiving antithrombotic therapy.
Methods
This study was a retrospective observational study held in a single institute. The patients undergoing gastric ESD from January 2009 to October 2014 were reviewed. Delayed bleeding rate in the patients receiving antithrombotic therapy was compared with that in matched controls. We also compared delayed bleeding rate in the patients continuing antithrombotic therapy with that in the patients with heparin bridging or cessation of antithrombotic therapy. Among 2388 lesions resected by gastric ESD, 367 lesions were resected in the patients with antithrombotic therapy, and 722 lesions were selected as controls. The lesions in the patients receiving antithrombotic therapy were divided into three subgroups: 54 lesions without preoperative cessation (continuation group), 37 lesions with heparin bridging (heparin group), and 276 lesions with cessation of antithrombotic therapy (cessation group).
Results
The incidence of delayed bleeding was significantly higher in the patients receiving antithrombotic therapy (9.5 % [35/367] vs. 4.2 % [30/722]; p < 0.01). Delayed bleeding rate in continuation group, heparin group, and cessation group was 9.2 % (5/54), 10.8 % (4/37), and 9.4 % (26/276), respectively, and no significant difference was observed. Thrombosis occurred only in cessation group (1.6 %).
Conclusions
Delayed bleeding rate associated with gastric ESD is significantly higher in the patients receiving antithrombotic therapy. No significant difference in delayed bleeding rate was observed among patients with and without cessation of antithrombotic therapy. To prevent thrombosis, gastric ESD without cessation may be feasible.
Similar content being viewed by others
References
Ogoshi K, Kaneko E, Tada M (2005) Tne management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastroenterol Endosc 47:2691–2695
Fujimoto K, Fujishiro M, Kato M, Higuchi K, Iwakiri R, Sakamoto C, Uchiyama S, Kashiwagi A, Ogawa H, Murakami K, Mine T, Yoshino J, Kinoshita Y, Ichinose M, Matsui T, Japan Gastroenterological Endoscopy S (2014) Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc 26(1):1–14. doi:10.1111/den.12183
Nakachi K, Iguchi M, Kato J (2015) Following JGES guidelines for patients with antiplatelet agents might increase bleeding after gastric endoscopic submucosal dissection. Dig Endosc 27(6):711. doi:10.1111/den.12493
Committee ASoP, Anderson MA, Ben-Menachem T, Gan SI, Appalaneni V, Banerjee S, Cash BD, Fisher L, Harrison ME, Fanelli RD, Fukami N, Ikenberry SO, Jain R, Khan K, Krinsky ML, Lichtenstein DR, Maple JT, Shen B, Strohmeyer L, Baron T, Dominitz JA (2009) Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc 70(6):1060–1070. doi:10.1016/j.gie.2009.09.040
Veitch AM, Baglin TP, Gershlick AH, Harnden SM, Tighe R, Cairns S, British Society of G, British Committee for Standards in H, British Cardiovascular Intervention S (2008) Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut 57(9):1322–1329. doi:10.1136/gut.2007.142497
Matsumura T, Arai M, Maruoka D, Okimoto K, Minemura S, Ishigami H, Saito K, Nakagawa T, Katsuno T, Yokosuka O (2014) Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents. BMC Gastroenterol 14(1):172. doi:10.1186/1471-230x-14-172
Kakushima N, Ono H, Tanaka M, Takizawa K, Yamaguchi Y, Matsubayashi H (2011) Endoscopic submucosal dissection using the insulated-tip knife. Tech Gastrointest Endosc 13(1):63–69. doi:10.1016/j.tgie.2011.02.002
Takizawa K, Oda I, Gotoda T, Yokoi C, Matsuda T, Saito Y, Saito D, Ono H (2008) Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection—an analysis of risk factors. Endoscopy 40(3):179–183. doi:10.1055/s-2007-995530
Oda I, Gotoda T, Hisanao H (2005) Endoscopic submucosal dissection for early gastric cancer: technical feasibility, operation time and complications from a large consecutive series. Dig Endosc 17:54–58
Mukai S, Cho S, Kotachi T, Shimizu A, Matuura G, Nonaka M, Hamada T, Hirata K, Nakanishi T (2012) Analysis of delayed bleeding after endoscopic submucosal dissection for gastric epithelial neoplasms. Gastroenterol Res Pract 2012:875323. doi:10.1155/2012/875323
Ono S, Ono M, Nakagawa M, Shimizu Y, Kato M, Sakamoto N (2015) Delayed bleeding and hemorrhage of mucosal defects after gastric endoscopic submucosal dissection on second-look endoscopy. Gastric Cancer. doi:10.1007/s10120-015-0507-y
Okada K, Yamamoto Y, Kasuga A, Omae M, Kubota M, Hirasawa T, Ishiyama A, Chino A, Tsuchida T, Fujisaki J, Nakajima A, Hoshino E, Igarashi M (2011) Risk factors for delayed bleeding after endoscopic submucosal dissection for gastric neoplasm. Surg Endosc 25(1):98–107. doi:10.1007/s00464-010-1137-4
Sanomura Y, Oka S, Tanaka S, Numata N, Higashiyama M, Kanao H, Yoshida S, Ueno Y, Chayama K (2014) Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer. Gastric Cancer 17(3):489–496. doi:10.1007/s10120-013-0305-3
Tounou S, Morita Y, Hosono T (2015) Continuous aspirin use does not increase post-endoscopic dissection bleeding risk for gastric neoplasms in patients on antiplatelet therapy. Endosc Int Open 3(1):E31–E38. doi:10.1055/s-0034-1390764
Lim JH, Kim SG, Kim JW, Choi YJ, Kwon J, Kim JY, Lee YB, Choi J, Im JP, Kim JS, Jung HC, Song IS (2012) Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms? Gastrointest Endosc 75(4):719–727. doi:10.1016/j.gie.2011.11.034
Cho SJ, Choi IJ, Kim CG, Lee JY, Nam BH, Kwak MH, Kim HJ, Ryu KW, Lee JH, Kim YW (2012) Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms. Endoscopy 44(2):114–121. doi:10.1055/s-0031-1291459
Gandhi S, Narula N, Mosleh W, Marshall JK, Farkouh M (2013) Meta-analysis: colonoscopic post-polypectomy bleeding in patients on continued clopidogrel therapy. Aliment Pharmacol Ther 37(10):947–952. doi:10.1111/apt.12292
Ono S, Fujishiro M, Yoshida N, Doyama H, Kamoshida T, Hirai S, Kishihara T, Yamamoto Y, Sakae H, Imagawa A, Hirano M, Koike K (2015) Thienopyridine derivatives as risk factors for bleeding following high risk endoscopic treatments: Safe Treatment on Antiplatelets (STRAP) study. Endoscopy. doi:10.1055/s-0034-1391354
Koh R, Hirasawa K, Yahara S, Oka H, Sugimori K, Morimoto M, Numata K, Kokawa A, Sasaki T, Nozawa A, Taguri M, Morita S, Maeda S, Tanaka K (2013) Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms. Gastrointest Endosc 78(3):476–483. doi:10.1016/j.gie.2013.03.008
Choi MK, Kim GH, do Park Y, Song GA, Kim DU, Ryu DY, Lee BE, Cheong JH, Cho M (2013) Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single-center experience. Surg Endosc 27(11):4250–4258. doi:10.1007/s00464-013-3030-4
Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT, Chiu PW, Leung VK, Wong VW, Chan FK (2010) Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med 152(1):1–9. doi:10.7326/0003-4819-152-1-201001050-00179
Acknowledgments
We wish to thank all the staff members in our institute for general help.
Author’s contribution
Kimihiro Igarashi was responsible for the data analysis and making a draft. Kohei Takizawa took responsibility for interpretation of the results and was involved with drafting this manuscript. Naomi Kakushima, Masaki Tanaka, Noboru Kawata, Masao Yoshida, Kinichi Hotta, Kenichiro Imai, Sayo Ito, Hirotoshi Ishiwatari, Hiroyuki Matsubayasi and Hiroyuki Ono made all important revisions to the manuscript. All of the authors read and agreed with submission of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Kimihiro Igarashi, Kohei Takizawa, Naomi Kakushima, Masaki Tanaka, Noboru Kawata, Masao Yoshida, Sayo Ito, Kenichiro Imai, Kinichi Hotta, Hirotoshi Ishiwatari, Hiroyuki Matsubayash and Hiroyuki Ono have no conflict of interest or financial ties to disclose.
Rights and permissions
About this article
Cite this article
Igarashi, K., Takizawa, K., Kakushima, N. et al. Should antithrombotic therapy be stopped in patients undergoing gastric endoscopic submucosal dissection?. Surg Endosc 31, 1746–1753 (2017). https://doi.org/10.1007/s00464-016-5167-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-016-5167-4